Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
153,624
Value
$414.8K
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of FATE by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026153,624$414.8K<0.1%+153,624NewHolders
Q4 20250$00.0%−15,554−100.0%Sold outHolders
Q3 202515,554$19.6K<0.1%−2,205−12.4%ReducedHolders
Q2 202517,759$19.9K<0.1%+17,759NewHolders
Q1 20250$00.0%−34,295−100.0%Sold outHolders
Q4 202434,295$56.6K<0.1%+20,805+154.2%AddedHolders
Q3 202413,490$47.2K<0.1%−115,269−89.5%ReducedHolders
Q2 2024128,759$422.3K<0.1%+128,759NewHolders
Q1 20240$00.0%−176,495−100.0%Sold outHolders
Q4 2023176,495$660.1K<0.1%−98,306−35.8%ReducedHolders
Q3 2023274,801$582.6K<0.1%+210,582+327.9%AddedHolders
Q2 202364,219$305.7K<0.1%−60,000−48.3%ReducedHolders
Q1 2023124,219$708.0K<0.1%−471,016−79.1%ReducedHolders
Q4 2022595,235$6.01M<0.1%+595,235NewHolders
Q3 20220$00.0%−13,207−100.0%Sold outHolders
Q2 202213,207$327.0K<0.1%+13,207NewHolders
Q1 20220$00.0%−25,739−100.0%Sold outHolders
Q4 202125,739$1.51M<0.1%−72,135−73.7%ReducedHolders
Q3 202197,874$5.80M<0.1%+91,416+1,415.5%AddedHolders
Q2 20216,458$560.0K<0.1%−8,811−57.7%ReducedHolders
Q1 202115,269$1.26M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.